mannkindcorp.com - MNKD Company profit before taxes, interest and amortization
MannKind Corporation develops inhalation products in the US, which minimizes geopolitical risks despite a reliance on Asian component imports. Operating cash flow before interest and taxes clearly demonstrates profit dynamics, where 18.01 serves as the final level marker. Robotic lines ensure dosing precision, while stable royalties from partners guarantee the company's financial stability.
Summary analytical data breakdowns for MannKind (MNKD)
- market value and analyst target forecast:
- issuer market value details:
- issuer book value statistics:
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio MannKind Corporation|MNKD - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio MannKind Corp|MNKD - Company Aggregate Debts|Debts to Book Capitalization MannKind|MNKD - Company Long-Term Debt|Company Short-Term Indebtedness MannKind|Immediate Liquidity Ratio mannkindcorp.com
- earnings and market ratios statistics:
MNKD - Company Net Income|Projected Future Earnings MannKind Corporation|MNKD - P/E Multiple|Market Cap to Projected Earnings mannkindcorp.com|MNKD - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation MannKind|MNKD - Operating profit EBITDA|Earnings per share for the last 12 months MannKind|MNKD - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months mannkindcorp.com|MNKD - Earnings growth in current year|Expected earnings per share growth for next year MannKind Corporation
- sales revenue and business income indicators:
Summary company analytics:MNKD (Afrezza)
This indicator eliminates information gaps between quarterly reports, revealing hidden systemic business risks. By analyzing the operating cash result, the investor tracks the actual intensity of cash inflows. The metric is calculated as the sum of operating profit before depreciation, excluding non-cash write-offs. This trend confirms the efficiency of MannKind Corporation (MNKD) robotic lines. Stable growth here signals the scaling of automated production while maintaining R&D expenditures.
Competitors of MannKind Corporation (MNKD)
Haleon Corp (HLN) - Profit before interest, taxes and amortization|KVUE: Operating profit before deduction of amortization|veronapharma.com - Company profit before taxes, interest and amortization|MENS: Operating profit EBITDA|Ligand Pharmaceuticals Incorporated - Income before deduction of interest, taxes and amortization|AMRX (Amneal Pharmaceuticals Inc) - Operating profit EBITDA|Profit before interest, taxes and amortization Perrigo Corp PRGO|Profit before payment of interest, taxes and amortization Alvotech (ALVO)|LQDA (liquidia.com) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Galapagos GLPG|ANIP - Operating profit before deduction of amortization|Amphastar - Operating profit EBITDA|PCRX - Operating profit EBITDA|ARS Pharmaceuticals (SPRY) - Profit before payment of interest, taxes and amortization|Operating profit before amortization TBPH|Profit before payment of interest, taxes and amortization Aquestive Therapeutics, Inc.|Operating profit before amortization SCPH (scPharma)|Profit before payment of interest, taxes and amortization Tectonic Therapeutic, Inc. (TECX)|Operating profit EBITDA Tonix Pharmaceuticals Holding (TNXP)|Operating profit EBITDA SXTC (China SXT Pharmaceuticals, Inc.)|Operating income before deduction of amortization Eupraxia Pharmaceuticals, Inc. (EPRX)|BHST - Profit before payment of interest, taxes and amortization|EXOZ (Invizyne Technologies) - Operating profit before amortization|ORMP: Operating profit EBITDA|Operating profit before amortization ENTX|Operating profit before deduction of amortization HYFT|ABVC: Income before deduction of interest, taxes and amortization|Operating profit EBITDA CPIX|Operating profit before deduction of amortization Quantum BioPharma Ltd. QNTM|Profit before payment of interest, taxes and amortization FibroGen Corp FGEN|Telomir Pharmaceuticals Corp (TELO) - Profit before interest, taxes and amortization|RANI - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization SNYR (Synergy CHC Corp)|rallybio.com (RLYB) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization LEXX (Lexaria Bioscience Corp.)|Profit before payment of interest, taxes and amortization Pulmatrix Corp|Profit before interest, taxes and amortization Pheton PTHL|Profit before payment of interest, taxes and amortization Aptorum Group Limited (APM)|LYRA (lyratherapeutics.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA IBO (Impact BioMedical)|Operating profit EBITDA TNF Pharmaceuticals Inc. TNFA|YCBD: Operating profit before deduction of amortization|PainReform Corp - Company profit before taxes, interest and amortization|CYTO: Operating profit EBITDA|LIPO - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization OptiNose|Profit before interest, taxes and amortization Pieris Pharmaceuticals Inc PIRS|Profit before payment of interest, taxes and amortization Procaps Group SA (PROC)|Petros Pharma - Operating profit before amortization|Profit before payment of interest, taxes and amortization Qilian International QLI|SLRN - Operating profit before deduction of amortization|TFFP - Profit before payment of interest, taxes and amortization
